Delivery Order SPE2DB22D2206-SPE2DB25FJC28
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,013.24 on July 25, 2025, for the supply of Sprycel 100 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and specifies a completion date of July 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $18,543.22 to AmerisourceBergen Drug Corp for the supply of Sprycel 70 mg tablets (60-count units). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract valued at $35,010.98. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order executed without set-aside designation. Performance of this pharmaceutical supply contract will be fulfilled from AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (60-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a $20,439.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The contract is a child delivery order under the company's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D3008|SPE2DX24F11LW) worth $23,962.98 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Sprycel 50 mg Tablet 60s, with an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, headquartered in Conshohocken, PA, is the prime contractor on this delivery order and has received multiple federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,142,252 units of the prescription medication Sprycel (100 mg tablet, 30-count) at a ceiling value of $11,701.09. The contract is a firm-fixed price, non-set-aside award with a period of performance through May 6, 2025. AmerisourceBergen holds a substantial Indefinite...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical valued at $5,448.13. The order is for 60 tablets of the 70mg dosage of the prescription medication Sprycel to support military treatment programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all goods and services delivered by November 29, 2023. No set-aside designation was applied to this order, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sprycel 100 mg tablets to support federal healthcare programs. The $5,322.66 firm fixed-price contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of Sprycel (Dasatinib) 100 mg tablets. The contract, valued at $45,165.44, has a completion date of November 22, 2022 and is a Firm Fixed Price arrangement. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC28Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sprycel 140 mg tablets (30-count units) under a firm fixed-price contract. The delivery order, valued at $5,570.37 with a completion date of July 29, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Sprycel is an oncology medication used in the treatment of certain blood cancers, reflecting the critical nature of pharmaceutical support provided through the DLA Medical Supply Chain to the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio and demonstrated capability to fulfill competitive procurements across multiple therapeutic domains position the company as a key pharmaceutical distributor for military and veteran healthcare needs. The rapid completion timeline from award to delivery indicates the urgent medical supply requirements being fulfilled through this transaction.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/28/25 |